The 4830C > A polymorphism within intron 5 affects the pattern of alternative splicing occurring within exon 6 of the thrombopoietin gene.
488 - 494.
Objective. A common variant in intron 5 of the thrombopoietin (TPO) gene (4830C > A) has been associated with risk of myocardial infarction (MI). To explore the molecular mechanism of this association, the ability of the intron to act as a transcription enhancer and to influence mRNA splicing was tested.Method and Results. In HepG2 cells the presence of intron 5 upstream of the TPO promoter decreased promoter activity to between 60 % and 30 %. This effect was orientation dependent; in the reverse orientation, intron 5 caused a twofold greater decrease in promoter activity compared to the forward orientation. However, the effects were similar with either the C or the 4830A allele. An in vitro exon trapping system was used to study the effect of the polymorphism on splicing events in exon 6. The full-length (TPO-1) and three previously reported splice variants (TPO-2, TPO-3, and TPO-5) were identified. The 4830A allele resulted in a small but statistically significant increase in production of the TPO-3 splice variant relative to the full-length transcript (10.6 % +/- 0.6 %) compared to the 4830C allele (8.3 % +/- 0.6 %) (p = 0.02). Generation of TPO-5 was also slightly increased, but this did not reach significance.Conclusion. The identification of a potential "silencer" sequence in intron 5 of the TPO gene demonstrates the complexity of control of expression of the gene. Although the precise role of the different splice variants is not known, the finding that the 4830C > A sequence change alters their relative amounts, suggests a possible molecular mechanism whereby TPO genotype may influence the risk of MI. (C) 2003 International Society for Experimental Hematology. Published by Elsevier Inc.
|Title:||The 4830C > A polymorphism within intron 5 affects the pattern of alternative splicing occurring within exon 6 of the thrombopoietin gene|
|Keywords:||MEGAKARYOCYTE GROWTH, MPL-LIGAND, HEREDITARY THROMBOCYTHEMIA, POINT MUTATION, MESSENGER-RNA, SITE, IDENTIFICATION, ISOFORMS, DISEASE|
|UCL classification:||UCL > School of Life and Medical Sciences > Faculty of Medical Sciences > Medicine (Division of) > Metabolism and Experimental Therapeutics
UCL > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute of Cardiovascular Science
Archive Staff Only